More Business Wire
View Older Stories View Newer Stories-
1NCE Continues Growth and Expands Its Software, AI and Services Offering
-
The Decisions That Will Shape Finance in 2026
-
Shenzhen Zhilai Sci and Tech Co. Collaborates with Applestone on Nicotine Vending
-
MoCA-XpressO Offers the Public a New Digital Resource to Check Memory and Cognitive Performance
-
Pavilion Payments Names Diallo Gordon CEO as Company Enters 2026 With Momentum
-
Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions
-
Navvis Named a Leader in the IDC MarketScape for U.S. Value-Based Care Strategic Consulting Services 2025-2026 Vendor Assessment
-
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
VideaHealth Launches AI Leadership Council to Shape the Future of Artificial Intelligence in Dentistry
-
Dykema Marks 100 Years in 2026, Launches Centennial Celebration
-
1031 CORP. Celebrates 35 Years of Empowering Clients to Achieve Their Real Estate Investment Goals
-
Software Finder Marks Third Consecutive Year of Triple-Digit Revenue Growth, Achieving 110% YoY in 2025
-
W3i Software to Build ShieldUSD: A Privacy-Preserving USD Stablecoin for the Midnight Network
-
DoiT Acquires SELECT to Eliminate Snowflake Waste
-
KnowBe4 Named #1 Leader in G2 Winter Grid Reports for Security Awareness Training and Incident Response Software
-
Newegg Brings Real-World PC Performance to Life at CES 2026
-
Walker & Dunlop and Pretium Introduce New Affordable Bridge Capital Joint Venture
-
BigHat Biosciences Partners With Lilly to Advance Machine-Learning-Enabled Biologics Discovery Through Lilly TuneLab
-
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
-
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer
-
Quantum to Participate at the Needham Growth Conference on January 15
-
iECURE Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ECUR-506 for Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency
-
New Directions Aromatics Partners with Aromatic Fragrances International To Create a Digitally Enabled Specialty Ingredients Platform
-
NeuraLight Reaches Key Milestone with Completion of International Multicenter Parkinson’s Clinical Trial
-
ClickShare Launches Its First Wireless Room System Bundles Certified for Microsoft Teams with Sennheiser
-
Forbes Honors Shift4 as one of America’s Most Successful Mid‑Cap Companies for 2026
-
Kelonia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KLN-1010, an in vivo BCMA CAR-T Therapy for Relapsed and Refractory Multiple Myeloma
-
Monster Energy Unleashes New ‘Ultra Punk Punch’ Flavor at Circle K
-
A10 Networks to Announce Fourth Quarter and Full Year 2025 Financial Results on February 4, 2026
-
Cairn Surgical Announces Completion of Enrollment in U.S. Pivotal Trial of Novel Breast Cancer Locator System
-
The New York Stock Exchange Enters Agreement with MSCI to Become the U.S. Options Listing Venue for Benchmark Indexes in Early 2026
-
Aramark Collegiate Hospitality and the University at Albany Forge Partnership to Integrate Campus Dining into the Learning Environment
-
The RMR Group Fiscal First Quarter 2026 Conference Call Scheduled for Thursday, February 5th
-
"Blind Automation" to "Assured Autonomy": 2026 Enterprise AI Predictions by iOPEX Technologies
-
Paul D. Clote, Esq., Joins JAMS in Houston
-
Hawaii Department of Transportation Creates Safer Roads with Bentley Systems’ Asset Analytics Solution
-
UK Credit Union Announces New, World-Class Member Experience Powered by Glia
-
Corsera Health Announces $80 Million Series A Financing and Reaches Key Clinical Milestone
-
ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
-
Empower Announces Partnership With PGA TOUR Golfer Cameron Young
-
Sagard Real Estate Expands U.S. Industrial Portfolio with Core-Plus Acquisition in Auburn, Washington
-
Pagaya Announces Timing of Fourth Quarter and Full Year 2025 Earnings Release
-
ConTeras Industrial Group Partners with Oaktree
-
Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer
-
Oklo and DOE Partner to Deploy Radioisotope Pilot Facility Supporting Cancer Care and U.S. Medical Supply Chains
-
Ventus Therapeutics Announces Nomination of VENT-04, a First-in-Class, Oral, Small-Molecule Caspase-4/5 Inhibitor, as a Development Candidate
-
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
-
Jumpmind Names New Chief Financial Officer and Chief Information Security Officer
-
CION Investment Corporation Declares Base Distributions Totaling $0.30 Per Share for Q1 2026
-
Nocion Therapeutics Extends Series B Financing to $93 Million to Support Late-Stage Development of Taplucainium in Chronic Cough
